Specialty Medicines


Specialty Medicines

Building on our strong heritage in inflammatory bowel disease (IBD), Ferring is developing a leading portfolio of life-changing treatments to support patients living with gastroenterological conditions.

Inflammatory bowel diseases

Inflammatory bowel diseases (IBDs) are chronic disorders causing inflammation and ulceration in sections of the digestive tract.

Clostridioides difficile infection

Clostridioides difficile is a bacterium that causes inflammation and is known to be one of the most common hospital-acquired infections.

Bladder cancer

Ferring aims to reduce unmet medical need through the development of a novel gene-based therapy.

Prostate cancer

Prostate cancer is one of the most common cancers to affect men and it is estimated that 1 in 5 will develop the disease during their lifetime.


In most cases, bedwetting is not caused by psychological or behavioural problems – it is a recognised medical disease that is common amongst children and some adults.

Discover more about Ferring

research in gastroenterology

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.


Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.


Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals


Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.


Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.


Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.